aTyr Pharma reported $12.51M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Ardelyx USD 202.83M 696K Dec/2025
aTyr Pharma USD 12.51M 12.11M Dec/2025
Biogen USD 6.29B 1.7M Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Cipla INR 3.82B 840.2M Mar/2026
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Grifols EUR 9.95B 722.93M Dec/2025
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
United Therapeutics USD 100M 100M Jun/2024
Xoma USD 94.38M 7.82M Sep/2025